Re: MUST READ-- metastatic her2+ breast cancer not necessarily the death sentence it
Thanks Lani
Really interesting research. The five year of herceptin keeps cropping up. I wonder if other chemos apart from taxotere would have the same lasting effect? I also wonder if the disease burden was a factor? Seems like the further research they are planning is very much needed
Ellie
|